Add BrightSurf on Google Email

JCI table of contents: December 1, 2006

In a study published in the Journal of Clinical Investigation, researchers used RNA interference (RNAi) to silence the gene encoding prion protein, suppressing its accumulation in mice. This breakthrough provides hope for developing a new therapeutic approach to treat neurodegenerative disorders like CJD and BSE. Further research is ne...

SourceJCI Journals·JournalJournal of Clinical Investigation·DateDec 1, 2006

Gene therapy for hereditary lung disease advances

Researchers have successfully tested a gene therapy to combat alpha-1 antitrypsin deficiency, a common hereditary disorder that causes lung and liver disease. The treatment showed no adverse effects and introduced the corrective gene into patients' blood, with some evidence of protein production.

SourceUniversity of Florida·JournalHuman Gene Therapy·DateNov 21, 2006

Cincinnnati scientists pursue new target for asthma treatment

Researchers have identified eosinophils as a major contributor to asthma symptoms, finding that they play a crucial role in mucous production and airway obstruction. The study suggests that targeting eosinophils could lead to the development of new treatments for asthma, which affects an estimated 17 million people in the US.

SourceUniversity of Cincinnati·JournalProceedings of the National Academy of Sciences·DateNov 20, 2006

JCI table of contents: October 19, 2006

Two studies published in the Journal of Clinical Investigation reveal key roles for PLC-gamma-2 and NF-kappa-B in immune responses. PLC-gamma-2 regulates osteoclast development and B cell differentiation, while NF-kappa-B controls endothelial cell function in models of sepsis and cancer.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateOct 19, 2006

New treatment approach holds promise for children infected by dangerous respiratory virus

Researchers at UTMB have developed an antioxidant treatment that reduces oxidative stress and inflammation caused by RSV, a common and dangerous early-childhood infection. The treatment, tested on laboratory mice, also lowers asthma-like symptoms after the virus has been cleared.

SourceUniversity of Texas Medical Branch at Galveston·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateOct 16, 2006

JCI table of contents: September 21, 2006

Researchers have identified calcineurin as essential for complete lung development, and its absence led to respiratory problems in mice. A new model of human placental development also sheds light on the complex process of placentation, while a study on thyroid structures reveals that mature T cells trigger their formation.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateSep 21, 2006

Calcineurin helps newborns breathe easy

In a study published in JCI Journals, researchers found that calcineurin is essential for complete lung development in mice. Mice lacking calcineurin function died shortly after birth due to lung failure.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateSep 21, 2006

Upgrading donor lung quality to improve availability

Researchers enhanced donor lungs using clinical maneuvers, increasing transplant procedures without compromising recipient function. The San Antonio Lung Transplant protocol improved lung procurement rates by up to 50%, reducing lengthy wait times and potentially eliminating deaths among patients awaiting lung transplantation.

SourceAmerican Thoracic Society·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateSep 15, 2006

World Trade Center dust cuts lung function capability in rescue workers

A large-scale study found that NYC firefighters' lung function declined by 12 years of age due to WTC dust exposure, with early arrival time-based periods showing more frequent respiratory symptoms. Researchers emphasize the importance of medical surveillance for high-risk jobs and call for better protective equipment.

SourceAmerican Thoracic Society·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateAug 1, 2006

Chemical in many air fresheners may reduce lung function

Researchers found a chemical compound in many air fresheners and deodorizing products may cause modest reductions in lung function. The study, published in Environmental Health Perspectives, analyzed blood concentrations of common volatile organic compounds and pulmonary function measures in a representative sample of adults.

SourceNIH/National Institute of Environmental Health Sciences·JournalEnvironmental Health Perspectives·DateJul 27, 2006

JCI table of contents: July 27, 2006

Researchers found that glucocorticoids (GCs) alter the activity of bone-forming and bone-degrading cells, leading to delayed bone formation and resulting in GC-induced osteoporosis. Antisense oligonucleotides can be delivered through cerebrospinal fluid to treat neurodegenerative diseases like ALS.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJul 27, 2006

Stopping inhaled corticosteroid use causes no problems in cystic fibrosis patient users

Researchers found that stopping inhaled corticosteroids in cystic fibrosis patients had no significant increase in lung-related adverse effects. The study showed that replacing the medication with a placebo was safe for most patients, suggesting that it may be possible to lower drug burden and reduce side effects.

SourceAmerican Thoracic Society·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateJun 15, 2006

Telephone counseling improves lung transplant quality of life

A study by Duke University Medical Center found that telephone counseling can improve the quality of life for patients waiting for a lung transplant, reducing emotional distress and anxiety. The researchers believe this approach could be useful for patients with chronic diseases who cannot access face-to-face counseling due to distance...

SourceDuke University Medical Center·JournalJournal of Consulting and Clinical Psychology·DateJun 5, 2006